EVA Air Cargo - Delivering Freshness
Cytiva Let's Talk

C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic Medicine

Tuesday, October 04, 2022

LogicBio Therapeutics Inc a pioneering clinicalstage genomic medicine company today announced that it has entered into a definitive agreement under which AstraZeneca Rare Disease will acquire LogicBio The proposed acquisition brings LogicBios unique...

Lineage Establishes New R&D Facility in U.S. and Expands Current GMP Manufacturing Facility in Israel

Tuesday, October 04, 2022

Lineage Cell Therapeutics Inc a clinicalstage biotechnology company developing allogeneic cell therapies for unmet medical needs announced today the opening of a new research and development RD facility in Carlsbad California and the expansion of its...

AmplifyBio Acquires Pact Pharma Assets to Enhance Cell and Gene Therapy Characterization Capabilities

Monday, October 03, 2022

AmplifyBio a contract research organization CRO focused on accelerating innovation across pharmaceutical modalities today announced the acquisition of select assets from PACT Pharma Inc a privately held biopharmaceutical company developing neoantigen...

Almirall and Simcere enter into a licensing agreement for IL-2-mu-Fc

Friday, September 30, 2022

Almirall SA a global biopharmaceutical company focused on skin health and Simcere Pharmaceutical GroupHK an innovation and RDdriven pharmaceutical company today announced that they have entered into an exclusive licensing agreement for Simceres IL mu...

McKesson Corporation Extends Pharmaceutical Distribution Agreement With CVS Health

Friday, September 30, 2022

McKesson Corporation announced that it has signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to mail order and specialty pharmacies retail pharmacies and distribution centers through June We are...

Visus Therapeutics Expands Ophthalmic Drug Development Portfolio With Acquisition of ViewPoint Therapeutics’ Assets

Thursday, September 29, 2022

Visus Therapeutics Inc a clinical stage biopharmaceutical company focused on developing multitargeted treatments for the eye today announced it has expanded its pipeline via the acquisition of all patents and other assets of ViewPoint Therapeutics In...

Thermo Fisher Scientific Launches a More Sustainable Solution for Large-Scale Cell Culture Harvesting

Thursday, September 29, 2022

Thermo Fisher Scientific Inc the world leader in serving science today unveiled the Thermo Scientific DynaSpin SingleUse Centrifuge system at the BioProcess International annual conference in Boston MA The system is specifically designed to provide a...

Koselugo approved in Japan for paediatric patients with plexiform neurofibromas in neurofibromatosis type 1

Wednesday, September 28, 2022

Koselugo selumetinib has been approved in Japan for the treatment of paediatric patients three years of age and older with plexiform neurofibromas PNs in neurofibromatosis type NF with clinical symptoms such as pain and disfigurement and PNs which c...

Scribe Therapeutics Announces Research Collaboration with Sanofi to Accelerate Breakthrough CRISPR-based Cell Therapies for Cancer

Wednesday, September 28, 2022

Scribe Therapeutics Inc a molecular engineering company pioneering a CRISPR by Design platform for genetic medicine today announced a strategic collaboration with Sanofi for the use of Scribes CRISPR genome editing technologies to enable genetic modi...

Atamyo Therapeutics Announces First Patient Dosed with ATA-100 Gene Therapy in LGMD-R9 Clinical Trial

Tuesday, September 27, 2022

Atamyo Therapeutics a biotechnology company focused on the development of newgeneration gene therapies targeting neuromuscular diseases today announced the dosing with ATA of a first patient in a phase clinical study in FRKPrelated limbgirdle muscul...

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEA SGS - ADVANCED ANALYTICS Adare Pharma Solutions - Pediatric Formulation Solutions Thermo Fisher Scientific - 60th year celebration of The Gibco brand Clarivate Pharmavision 2022 Thermo Fisher Scientific - LC-MS biopharmaceutical applications
banner